A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
According to Anthropic's own published blog post, the company is calling for a global moratorium on frontier AI development, warning that models could begin recursively self-improving and escape human oversight before the industry has tools to stop them. The timing is pointed: Anthropic is simultaneously preparing an initial public offering at a reported valuation north of $1 trillion.
The post argues there is a narrow window to establish binding guardrails before models become capable of accelerating their own advancement — a scenario Anthropic's researchers say would render existing safety frameworks obsolete. CEO Dario Amodei has made existential risk the company's founding thesis, but that argument lands differently when it accompanies a fundraising trajectory that would make Anthropic one of the most valuable companies on Earth.
Critics moved fast on the obvious tension: a freeze on frontier development, if actually enforced, benefits the companies already at the frontier. Anthropic sits in that very small group alongside OpenAI and Google DeepMind — the handful of organizations with the compute and talent to be considered truly frontier. Using regulatory pressure to lock in that position is a strategy as old as incumbency.
Whether Dario Amodei is the most serious safety thinker in Silicon Valley or its most sophisticated incumbent, the honest answer is probably both.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division